Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

GENE:

SETBP1 (SET Binding Protein 1)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related tests:

SETBP1 mutation	Myelodysplastic Syndrome	SETBP1 mutation	Myelodysplastic Syndrome	ruxolitinib Sensitive: A2 - Guideline ruxolitinib Sensitive : A2	ruxolitinib Sensitive: A2 - Guideline ruxolitinib Sensitive : A2
SETBP1 expression	Acute Myelogenous Leukemia	SETBP1 expression	Acute Myelogenous Leukemia	venetoclax Sensitive: C3 – Early Trials venetoclax Sensitive : C3	venetoclax Sensitive: C3 – Early Trials venetoclax Sensitive : C3
SETBP1 mutation	Myelodysplastic Syndrome	SETBP1 mutation	Myelodysplastic Syndrome	azacitidine Resistant: C3 – Early Trials azacitidine Resistant : C3	azacitidine Resistant: C3 – Early Trials azacitidine Resistant : C3
SETBP1 mutation	Non Small Cell Lung Cancer	SETBP1 mutation	Non Small Cell Lung Cancer	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
SETBP1 mutation	Melanoma	SETBP1 mutation	Melanoma	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3	Immunotherapy Sensitive: C3 – Early Trials Immunotherapy Sensitive : C3
SETBP1 mutation + NRAS mutation	Juvenile Myelomonocytic Leukemia	SETBP1 mutation + NRAS mutation	Juvenile Myelomonocytic Leukemia	trametinib Sensitive: D – Preclinical trametinib Sensitive : D	trametinib Sensitive: D – Preclinical trametinib Sensitive : D